Dr. Gregory Alan Joice, MD

Dr. Joice practices at Columbia Vascular Surgery at Columbia University Irving Medical Center's Herbert Irving Pavilion - Laboratory in New York, New York.

Dr. Joice's NPI, 1376980037, was assigned on June 3, 2013. Dr. Joice graduated from Vagelos College of Physicians and Surgeons in 2014. Dr. Joice holds New York license 310304.

Dr. Joice's primary practice is Columbia Vascular Surgery at Columbia University Irving Medical Center's Herbert Irving Pavilion - Laboratory, at 161 Ft Washington Ave - 5th Fl, New York, NY 10032. The practice phone is (212) 305-1028.

Dr. Joice's primary practice is Columbia Vascular Surgery at Columbia University Irving Medical Center's Herbert Irving Pavilion - Laboratory in New York, New York. Dr. Joice is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Joice to 2 more group practices and clinics and 2 medical groups, each named with a free account. Dr. Joice's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Joice practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Joice's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Joice is board certified in urology by the American Board of Urology. Dmand AI has Dr. Joice's licenses on file in 2 states: New York and Texas.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney stone disease and prostate cancer among the conditions Dr. Joice treats.

CMS data shows 310 Medicare services from Dr. Joice across 5 procedure codes in 2024, for 194 Medicare patients. Medicare paid $31,204 for them. Every service was in an office.

CMS counts 194 Medicare patients who saw Dr. Joice in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 30% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Joice's median patient age at 63, with 10% women.

In 2024, Dr. Joice wrote 324 Medicare Part D claims for 115 patients. 83% of them were for generic drugs. CMS names the drug for 222 of them, across 9 drugs with 11 or more claims each, at $22,916 in total drug cost. In 2023, CMS named 195 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Joice for performance year 2024, reported through an alternative payment model (APM). Dr. Joice accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Joice as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 65 papers to Dr. Joice, published from 2013 to 2025. 2017 was the busiest year, with 12. The most frequent topics are Postoperative Complications, Urinary Sphincter, Artificial and Urethra. Dr. Joice has published most often in Urology. Dr. Joice's most frequent co-authors are Nikolai Anton Sopko, MD, PhD, Mohamad E. Allaf, MD and Steven Jeffrey Hudak, MD.

CMS Open Payments shows 211 general payments to Dr. Joice from 18 drug and device companies from 2020 to 2025. Grants make up the largest share, 82% of the total. Boston Scientific Corporation paid the most, $57,449.

Dr. Joice graduated from Vagelos College of Physicians and Surgeons in 2014.

Dr. Joice is in network with 10 carriers, including Aetna, Elevance and MVP Health Care. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.